CELLINK is proud to be a part of BICO, the world’s leading bioconvergence company, which leverages the synergies of its premier companies in engineering, robotics, artificial intelligence, advanced genomics and bioprinting to create the future of health. We offer premium bioinks, bioprinters and services that enable critical breakthroughs in 3D cell culturing, tissue engineering and drug development. CELLINK’s products are trusted by more than 1,000 laboratories, including ones at all the top 20 pharmaceutical companies, are being used in more than 65 countries, and have been cited in more than 1,600 publications.